Kate Bingham is a seasoned investment professional with extensive experience in the healthcare sector, currently serving as Managing Partner at SV Health Investors since September 1991. In 2020, Kate Bingham held the position of Chairman of the UK Vaccine Taskforce, leading efforts during a critical period. Academically, Kate Bingham earned an MBA in Business from Harvard Business School from 1989 to 1991 and a BA in Biochemistry from the University of Oxford from 1983 to 1987.